B1IIL7 AF NFT

Probable dual-specificity RNA methyltransferase RlmN

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeidaqtyvtjpo3e7w46jiun2kw6dbz3sfwkigk2d4turgrtocyr2dke/metadata.json
IPFS of structure file: 
bafybeiedx6dgo4rjvvw4hy4rhx7reat3a3wqjox6u5avit2z2a7yn77zji/AF-B1IIL7-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xe9D866648c015EfcD61c462afEC39fc6c58DC2b5
First NFT owner address (bech32): 
genesis1a8vxveyvq900e4sugc40asulcmzcms447uegfm
Current NFT ID #378200 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
378200
Accession (UniProt):
B1IIL7
Name::
Probable dual-specificity RNA methyltransferase RlmN
Experimental Method:
Predicted structure
Sequence source:
Clostridium botulinum (strain Okra / Type B1)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B1IIL7 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B1IIL7|RLMN_CLOBK Probable dual-specificity RNA methyltransferase RlmN OS=Clostridium botulinum (strain Okra / Type B1) OX=498213 GN=rlmN PE=3 SV=1 MENILDFTLEELKEWLISKEEKAFRAKQVFDWIYNKLIFDFNNMKNIPYKTKNLLSDNFYIGVPKVVKKLMSQDKNTYKFLFEYKDGNIIESVVMKYKHGNSICVSTQVGCRMGCKFCASTLDGVIRNLTSGEILSQIMAAQKEIGERISNVVLMGSGEPLDNFENVTKFLDLVTSDTTLNIGQRHITLSTCGIVPKIKELADKNYNITLAISLHSPEDLLRKEMMPIANKYSIKELMEACDYYINKTNRRITFEYALVKGKNDSIKEAKKLSTVLKGKLCHVNLIPVNEIKENSYEKSTLKNIESFGNILKENGIETTIRREMGADINAACGQLRRSYVSK